cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vericel Corporation
7 own
8 watching
Current Price
$46.74
$-1.23
(-2.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,716.32M
52-Week High
52-Week High
53.05000
52-Week Low
52-Week Low
30.18000
Average Volume
Average Volume
0.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
243.8501
iconMarket Capitalization1,716.32M
icon52-Week High53.05000
icon52-Week Low30.18000
iconAverage Volume0.32M
iconDividend Yield--
iconP/E Ratio243.8501
What does the Vericel Corporation do?
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, markets, and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets three autologous cell therapy products, including Carticel and MACI, which are used for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement that is used for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States. The company also develops ixmyelocel-T, which is in Phase IIb clinical trial, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was founded in 1989 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Vericel Corporation make?
News & Events about Vericel Corporation.
Globe Newswire
1 year ago
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO will present at the Canaccord Genuity Musculoskeletal Conference. The ...
Globe Newswire
1 year ago
Record Fourth Quarter Total Revenue of $52.7 Million and 31% Net Income Growth Full-Year 2022 Total Revenue of $164.4 Million, with MACI Revenue of $132 Million Full-Year 2023 Total Revenue Guidance of $180 to $188 Million, with MACI Revenue of $152 to $156 Million Conference Call Today at 8:30am ...
Ticker Report
1 year ago
Vericel (NASDAQ:VCEL Get Rating) and ERYTECH Pharma (NASDAQ:ERYP Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its fourth-quarter 2022 financial results on Thursday, February 23, 2023. Vericels ...
Benzinga
1 year ago
Latest Ratings for VCEL DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Dec 2021Truist SecuritiesMaintainsBuy Aug 2021SVB LeerinkMaintainsOutperform View More Analyst Ratings for VCEL View the Latest Analyst Ratings read more...
Frequently Asked Questions
Frequently Asked Questions
What is Vericel Corporation share price today?
plus_minus_icon
Can Indians buy Vericel Corporation shares?
plus_minus_icon
How can I buy Vericel Corporation shares from India?
plus_minus_icon
Can Fractional shares of Vericel Corporation be purchased?
plus_minus_icon
What are the documents required to start investing in Vericel Corporation stocks?
plus_minus_icon
What is today’s traded volume of Vericel Corporation?
plus_minus_icon
What is today’s market capitalisation of Vericel Corporation?
plus_minus_icon
What is the 52-Week High and Low Range of Vericel Corporation?
plus_minus_icon
What percentage is Vericel Corporation down from its 52-Week High?
plus_minus_icon
What percentage is Vericel Corporation up from its 52-Week Low?
plus_minus_icon
Current Price
$46.74
$-1.23
(-2.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00